Table1.
Baseline characteristics
| All | Covid19 | Non-Covid19 | p value | |
|---|---|---|---|---|
| Female | 26/66 (39.39%) | 4/11 (36.36%) | 22/55 (40%) | 1.000 |
| 28 days survival | 40/66 (60.61%) | 8/11 (72.73%) | 32/55 (58.18%) | 0.505 |
| Duration of ICU stay [days] | 16.73 (9.36–29.90) | 27.89 (11.98–33.23) | 14.71 (9.15–24.76) | 0.404 |
| Duration of V-V ECMO [days] | 7.82 (4.41–17.97) | 17.94 (7.8–23.75) | 7.49 (4.15–16.34) | 0.242 |
| Indication for anticoagulation prior to V-V ECMO | 10/66 (15.15%) | 1/11 (9.09%) | 9/55 (16.36%) | 1.000 |
| Height [cm] | 174.5 (168.8–180) | 175 (170–180) | 173 (165–180) | 0.430 |
| Body weight [kg] | 80 (70.23–90) | 85 (79–95) | 77.50 (70–90) | 0.621 |
| Body-Mass-Index | 24.69 (23.51–31.05) | 27.78 (25.06–33.87) | 24.22 (23.49–30.86) | 0.8450 |
| Age [years] | 58.36 (46.85–66.23) | 59.38 (49.81–61.05) | 58.12 (44.35–66.51) | 0.808 |
| APACHE II | 23.5 (18.75–30) | 29 (27–30) | 22 (18–31) | 0.104 |
| SOFA | 12 (10–14.25) | 14 (13–16) | 12 (9–14) | 0.015 |
| RESP Score | 1 ((−1)−3) | 1 (0–2) | 1 ((−2)−4) | 0.845 |
APACHE II acute physiology and chronic health score, RESP Score respiratory extracorporeal membrane oxygenation survival prediction score, SOFA sepsis-related organ failure assessment score